Renal and Urinary Tract Cancer Clinical Trials
CPMC Cancer ServicesOpens new window
Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Active Trials
Title: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma
Description: Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Investigators: CPMC Oncologists
Eligibility: Subjects who have been diagnosed with transitional cell carcinoma of the urinary tract
Status: Active and open to enrollment
Contact: Chrissy Raymundo, 415-600-1775,
Email: RaymunCL@cpmcri.org about Study CALGB 90601
Trials: Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma
Description: Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
Investigator: David Minor, MD
Eligibility: Subjects who have been diagnosed with advanced renal cell carcinoma (kidney cancer)
Status: Active but closed to enrollment
Contact: Brenda Eng, 415-600-1775,
Email: EngB@cpmcri.org about Study Wyeth 3066-3311
- updated May 2011
Back to top